Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
Intervention1: Polyherbal unani formulation of,
Suranjan sheerin(colchicum luteum),3.5 gram
Zanjabeel khushk(zinjiber officinalis), 3.5 gram
Sibr(aloe barbadensis), 7 gram: Dosage form: Safuf (powder)
Suranjan sheerin(colchicum luteum),3.5 gram
Zanjabeel khushk(zinjiber officinalis), 3.5 gram
Sibr(aloe barbadensis), 7 gram
Control Intervention1: Febuxostat: Febuxostat,
Dosage form: Tablet,
Dose:
Sponsors
FARHA LUQMAN
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed patient of Gout with raised Serum uric acid level beyond normal limit Both sexes Clinically stable Patient
Exclusion criteria
Exclusion criteria: Patient below 20 and above 65 years. Gout with Diabetic Mellitus. Pregnant women and lactating mother. Severe illnesses of debilitated patients of cardiovascular system ,respiratory system, severe renal or hepatic insufficiency, gastro- intestinal problems, nervous system and malignant growth. Any other type of arthritis such as Rheumatoid Arthritis, Osteoarthritis etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to treatment will be assessed using the following parameter 1-Reduction in uric acid 2-Reduction in C. Reaction 3-Improvement in Patients Global Assessement (PGA) based on VASTimepoint: 2week 4 week 6 week 8 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effect kidney function test liver function test haemoglobinTimepoint: 8 week | — |
Countries
India
Contacts
Public ContactDr Mohd Zubair
Stat,e Takmeel-ut-Tib College and Hospital
Outcome results
None listed